NDC 55154-2632-00 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-2632
- Requested NDC
- 55154-2632-00
- Package NDCs from labels
- 55154-2632-0, 55154-2632-00
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-2632-0 | Oxybutynin Chloride | 1 in 1 BLISTER PACK | TABLET | 1 | 3 | |
| 55154-2632-0 | Oxybutynin Chloride | 10 in 1 BAG | TABLET | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-2632 | OXYBUTYNIN CHLORIDE TABLET [CARDINAL HEALTH 107, LLC] | 2 | Current NDC, 2 package rows | 20250108_8455b543-81ce-4522-ae9b-8396f944945c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3a319017-4e25-402e-8ba0-63b9f1eb707e | 2026-11-04 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | e466d963-469a-4b1c-87f9-2e3e1e9bdf3d | 2026-11-02 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2026-11-02 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Cardinal Health 107, LLC | 8455b543-81ce-4522-ae9b-8396f944945c | 2026-10-12 | Warnings, Adverse reactions | ANDA209823 55154-2632-0 55154-2632 55154263200 863664 fabef94b-3b42-4cb1-bcac-943256ec715f 8455b543-81ce-4522-ae9b-8396f944945c L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Preferred Pharmaceuticals Inc. | 0e002fe8-fa3f-4a7d-84df-0c6e031e6ae4 | 2026-10-09 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | a1674ddc-44f5-4638-8415-ef02ab6af7cc | 2026-09-18 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | Redpharm Drug | 5b432aae-8a9d-8846-e063-6394a90a3b0d | 2026-09-12 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | REMEDYREPACK INC. | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 2026-07-28 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | TruPharma LLC | 7c497c6c-2448-2c80-e053-2991aa0ab8c7 | 2026-07-27 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | 9578b6b8-5b9d-4263-9142-39b2c7216b85 | 2026-07-21 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | ATLANTIC BIOLOGICALS CORP. | fe4ed76b-0009-455f-be30-47e80fc1afdf | 2026-07-09 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 55f618d1-4463-3200-e063-6394a90a89a8 | 2026-07-06 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | 9ede5def-d185-4e40-9c10-8663ac654caf | 2026-07-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | American Health Packaging | 0c71bdfb-01db-49ac-a8e9-0037df0d24af | 2026-06-24 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | ac10c7b7-d0cb-4068-93e2-c0e51f15866e | 2026-06-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 73d715dc-868d-4194-b668-4c39ababa698 | 2026-05-20 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | a5965c8b-179d-4665-8a3b-324b693607ee | 2026-05-19 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 7db4ab81-b379-4a6d-b469-95eb9e184b56 | 2026-05-14 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | American Health Packaging | 4574b227-9726-4798-bac2-83bfb9616f09 | 2026-04-16 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | b9d0e5c8-3a71-40a0-a7d3-44bc043392fa | 2026-02-17 | Warnings, Adverse reactions | L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.